Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Epirubicin or Pirarubicin|DRUG: Cyclophosphamide
Sponsor: Chinese Academy of Medical Sciences